Form 4: TScan Therapeutics Executive Receives Stock Grant
Insider Transaction (Form 4)
Zoran Zdraveski, See Remarks of TScan Therapeutics, Inc., received 300,000 shares of common stock on October 1, 2026.
Summary
- Grant/award: acquired 300,000 Voting Common Stock on October 1, 2026; holds 304,716 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Zoran Zdraveski — Officer (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Grant/award | Voting Common Stock | 300,000 | — | — | 304,716 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Grant/award (300,000 shares) |
Keywords
insider transaction, Form 4, TCRX, TScan Therapeutics, Inc., neutral, Zoran Zdraveski
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.